| 開發人員: | Medable Inc. (171) | ||
| 價錢: | 免費 | ||
| 排名: | 0 | ||
| 評測: | 0 寫評論 | ||
| 清單: | 0 + 0 | ||
| 點數: | 0 + 12 (4.0) ¡ | ||
| Google Play | |||
描述
The Medable app connects people to their sponsors’ clinical trials, offering a complete eCOA solution that includes:
- Digital data collection
- Electronic patient-reported outcome (ePRO)
- eDiaries and questionnaires
- Schedule of your visits and activities
- Televisit
- Notifications and reminders
- Trial resources
- Integrations with select sensors, wearables, and more.
螢幕擷取畫面
價錢
- 今天: 免費
- 最小值: 免費
- 最大值: 免費
追蹤票價
開發人員
- Medable, Inc.
- 平台: Android 應用程式 (66) iOS 應用程式 (105)
- 清單: 0 + 0
- 點數: 1 + 34 ¡
- 排名: 0
- 評測: 0
- 折扣: 0
- 影片: 0
- RSS: 訂閱
點數
0 ☹️
排名
0 ☹️
清單
0 ☹️
評測
成為第一個評論 🌟
其他資訊
- 版本: 5.12.0.5-prod
- 類別 :
Android 應用程式›醫療 - OS:
Android 8.0 - 大小:
26 Mb - 內容分級:
Everyone - Google Play 評分:
4.0(12) - 發佈日期:
- 發行日期:
聯絡人
- 個人網站:
http://www.medable.com
Medable 縮短網址: 已複製!- 🌟 分享
- Google Play
你可能還喜歡
-
- Medable TeleVisit
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.10.1 This app will be used to virtually connect sites and subjects via TeleVisit functionality. ⥯
-
- GSK 219855 France
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 5.4.800.14-prodFrance You are invited to participate in the GSK BLISSc-ILD OLE study. This application is intended to support a clinical research trial by Glaxo Smith Kline. This application allows patients ⥯
-
- ZEUS Study App (EX6018-4758)
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 1 + 0 版本: v2.9.0 This app is specifically intended for study participants in the ZEUS (EX6018-4758) study only. ⥯
-
- NN7769-4516 Participant
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: v3.1.1 This app is specifically intended for study participants in the Frontier3 (NN7769-4516) study only. ⥯
-
- NN7769-4532 Participant
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: v1.7.0 This app is specifically intended for study participants in the Frontier4 (NN7769-4532) study only. ⥯
-
- P23-899 Patient
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 5.2.1000.01-prod You are invited to participate in the P23-899 study. ⥯
-
- BMS CA116-003 FR
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 5.0.700.01-prod_france You are invited to participate in the Bristol Myers Squibb CA116-003 study. This app is specifically intended to capture MORAb-202 (farletuzumab etceteribulin) reactions and symptoms. ... ⥯
-
- LOUiSSe
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.8.2 This is a study application for subjects participating in the LOUiSSe Novartis clinical trial, and investigators. ⥯
-
- BGB-215 Wellbeing Activity App
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.8.1.8 This is a study application for subjects participating in the BeiGene BGB-3111-215 Wellbeing Activity Project ⥯
-
- SIGA Mobile Patient App
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.8.1 The SIGA Mobile Patient app is utilized for patients participating in the 246-021 study. ⥯
-
- YTB323
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.7.0.1 This is a study application for investigators in the YTB323 Novartis clinical trial. ⥯
-
- MEDI5752 RCC Study
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.10.1 You are invited to participate in the MEDI5752 RCC study. By installing the MEDI5752 RCC app on your phone, you are able to provide real-time blood pressure and heart rate data, ... ⥯
-
- Denali TeleVisit
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.10.1 This app can be used to connect with your physician via TeleVisit. ⥯
-
- SAAVY (270-701)
- Android 應用程式: 醫療 由: Medable Inc.
- 免費
- 清單: 0 + 0 排名: 0 評測: 0
- 點數: 0 + 0 版本: 4.11.2 This app is specifically intended for study participants in the BioMarin Pharmaceuticals Inc. (270-701) Seroprevalence and Seroconversion Study ⥯